BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Diagnosis
775 results:

  • 1. Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa.
    Govind K; Paruk IM; Motala AA
    BMC Endocr Disord; 2024 Apr; 24(1):53. PubMed ID: 38664758
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Outcomes of the patients with metastatic male breast cancer.
    Dogan I; Khanmammadov N; Ozkurt S; Aydiner A; Saip P
    J Cancer Res Ther; 2024 Jan; 20(1):98-102. PubMed ID: 38554305
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study.
    Çağlayan Ş; Koç BŞ; Baba Ö; Bağlan E; Kurucu B; Yıldırım DG; Ayhan AC; Çakan M; Yener GO; Öztürk K; Çakmak F; Sönmez HE; Ayaz NA; Kısaarslan AP; Bakkaloğlu S; Kalyoncu M; Kılıç SÇ; Sözeri B
    Turk J Pediatr; 2024; 66(1):81-89. PubMed ID: 38523382
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prospective evaluation of 68 Ga-NODAGA-RGD PET-CT in patients of carcinoma thyroid with thyroglobulin elevated negative radioiodine scintigraphy (TENIS) with a head-to-head comparison with FDG-PET/CT.
    Gondhane A; Verma P; Chandak A; Basu S
    Nucl Med Commun; 2024 May; 45(5):412-419. PubMed ID: 38445350
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM).
    Fan H; Wang B; Shi L; Pan N; Yan W; Xu J; Gong L; Li L; Liu Y; Du C; Cui J; Zhu G; Deng S; Sui W; Xu Y; Yi S; Hao M; Zou D; Chen X; Qiu L; An G
    Clin Cancer Res; 2024 Mar; 30(6):1131-1142. PubMed ID: 38170583
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Imaging diagnosis and efficacy monitoring by [
    He H; Qi X; Fu H; Xu J; Zheng Q; Chen L; Zhang Y; Hua H; Xu W; Xu Z; Chen X; You Q; Lin J; Huang G; Mao Y; Yu C
    Theranostics; 2024; 14(1):392-405. PubMed ID: 38164149
    [No Abstract]    [Full Text] [Related]  

  • 7. Diagnostic challenges in low-grade central osteosarcoma.
    Khal AA; Aiba H; Righi A; Gambarotti M; Atherley O'Meally AO; Manfrini M; Donati DM; Errani C
    Bone Joint J; 2024 Jan; 106-B(1):99-106. PubMed ID: 38160683
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. EFFECT OF IRON ON bone TISSUE METABOLISM AND THYROID FUNCTION IN CHILDREN LIVING ON RADIOLOGICALLY CONTAMINATED TERRITORIES SINCE THE ChNPP ACCIDENT.
    Bazyka DA; Bruslova KM; Liashenko LO; Pushkareva TI; Tsvyetkova NM; Galkina SG; Kondrashova VG; Zaytseva AL; Gonchar LO; Kuzmenko VF; Trychlіb IV; Kavardakova NV; Chernysh TO; Pismennyj VD; Pleskach OY
    Probl Radiac Med Radiobiol; 2023 Dec; 28():225-238. PubMed ID: 38155125
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinico-pathological profile of patients with plasma cell neoplasms with special reference to bone marrow fibrosis and amyloid deposition.
    Kannan N; Dass J; Dangudubiyyam S; Viswanathan GK; Aggarwal M; Kumar P; Dhawan R; Seth T; Mahapatra M
    J Clin Exp Hematop; 2023; 63(4):214-218. PubMed ID: 38148011
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Circulatory bone morphogenetic protein (BMP) 8B is a non-invasive predictive biomarker for the diagnosis of non-alcoholic steatohepatitis (NASH).
    Mounika N; Yadav A; Kamboj P; Banerjee SK; Deka UJ; Kaur S; Adela R
    PLoS One; 2023; 18(12):e0295839. PubMed ID: 38127951
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.
    Sobas M; Knopinska-Posluszny W; Piątkowska-Jakubas B; García-Álvarez F; Díez MEA; Caballero M; Martínez-Cuadrón D; Aguiar E; González-Campos J; Garrido A; Algarra L; Salamero O; de la Serna J; Sayas MJ; Perez-Encinas MM; Vives S; Vidriales B; Labrador J; Prado AI; Celebrin L; Mayer J; Brioso J; de Laiglesia A; Bergua JM; Amigo ML; Rodriguez-Medina C; Polo M; Pluta A; Cichocka E; Skarupski M; Sanz MA; Wierzbowska A; Montesinos P
    Ann Hematol; 2024 Feb; 103(2):451-461. PubMed ID: 38110588
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Determinants of bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate cancer in a National Health Care Delivery System.
    Nguyen CB; Kobe C; Kumbier KE; Bauman J; Burns JA; Tsao PA; Sparks JB; Skolarus TA; Caram MEV
    JCO Oncol Pract; 2024 Jan; 20(1):59-68. PubMed ID: 38085028
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Enhancing bone cancer diagnosis Through Image Extraction and Machine Learning: A State-of-the-Art Approach.
    Shrivastava A; Nag MK
    Surg Innov; 2024 Feb; 31(1):58-70. PubMed ID: 38059371
    [No Abstract]    [Full Text] [Related]  

  • 14. HLA-B27 did not protect against COVID-19 in patients with axial spondyloarthritis - data from the ReumaCov-Brasil Registry.
    Mota GD; Marques CL; Ribeiro SL; Albuquerque C; Castro G; Fernandino D; Omura F; Ranzolin A; Resende G; Silva N; Souza M; Studart S; Xavier R; Yazbek M; Pinheiro MM
    Adv Rheumatol; 2023 Nov; 63(1):56. PubMed ID: 38031143
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Risk factors for distant metastasis of Chondrosarcoma in the middle-aged and elderly people.
    Deng GH
    Medicine (Baltimore); 2023 Nov; 102(44):e35562. PubMed ID: 37932996
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Assessing survival outcomes and complication profiles following surgical excision and radiotherapy as interventions for skull base chordoma: a systematic review of operative margins and surgical approaches.
    Brown NJ; Gendreau J; Kuo CC; Nguyen O; Yang C; Catapano JS; Lawton MT
    J Neurooncol; 2023 Oct; 165(1):41-51. PubMed ID: 37880419
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Diagnostic value of WB-DWI versus
    Zhang B; Zhang L; Bian B; Lin F; Zhu Z; Wang J
    Indian J Cancer; 2023; 60(3):303-309. PubMed ID: 37787189
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Diagnostic capability of 18F-PSMA PET-MRI and pelvic MRI plus bone scan in treatment-naive prostate cancer: a single-center paired validating confirmatory study.
    Qiao Z; Wang S; Wang H; He B; Shi Z; Zhou H; Yang Q; Chen X; You Z; Zhao J; Wang H
    Int J Surg; 2024 Jan; 110(1):87-94. PubMed ID: 37738021
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis.
    Ruan D; Zhao L; Cai J; Xu W; Sun L; Li J; Zhang J; Chen X; Chen H
    Theranostics; 2023; 13(13):4694-4710. PubMed ID: 37649615
    [No Abstract]    [Full Text] [Related]  

  • 20. Spectral CT assists differentiation of osteoblastic bone metastasis from bone island in newly diagnosed cancer patients.
    Luo H; Zou L; Yang Q; Yuan C; Ma K; Yang S; Luo D; Liu C; Liu Z
    Eur Radiol; 2024 Jan; 34(1):60-68. PubMed ID: 37566265
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 39.